Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative

Adriana Báez1, Alan Cantor, Sharon Fonseca

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Puerto Rico School of Medicine, San Juan, Puerto Rico. abaez@rcm.upr.edu

Insights

Head and neck squamous cell carcinomas (HNSCC) involve transforming growth factor beta (TGF-beta) signaling. This study found significantly lower Smad4 expression in HPV16-positive HNSCC tumors, suggesting a role in HPV16-induced carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor beta (TGF-beta) signaling, mediated by SMAD proteins, is crucial for cellular regulation.
  • Disruption of TGF-beta signaling is implicated in head and neck squamous cell carcinomas (HNSCC).
  • The tumor suppressor gene DPC4/Smad4 is vital for TGF-beta signaling and frequently altered in various cancers; HPV16 may interfere with its function.

Purpose of the Study:

  • To investigate the correlation between TGF-beta signaling pathway components (Smad2, Smad2-P, Smad4) and HPV16 status in HNSCC.
  • To determine if HPV16 infection influences the expression of key SMAD proteins in HNSCC development.

Main Methods:

  • Immunohistochemistry was used to examine the expression of Smad2, phosphorylated Smad2 (Smad2-P), and Smad4.
  • Expression patterns were analyzed in 43 HNSCC tumors, categorized as HPV16-negative (n=27) and HPV16-positive (n=16).
  • Statistical analysis compared protein expression levels between HPV16-positive and HPV16-negative tumor groups.

Main Results:

  • No significant differences in Smad2 or Smad2-P expression were observed between HPV16-positive and HPV16-negative HNSCC tumors.
  • A statistically significant decrease in Smad4 expression was found in 56% of HPV16-positive tumors compared to 39% of HPV16-negative tumors (P = 0.01).

Conclusions:

  • Loss of Smad4 expression is significantly associated with HPV16-positive HNSCC.
  • These findings suggest that reduced Smad4 expression may play a role in HPV16-induced head and neck squamous cell carcinoma development.